Results 1 to 10 of about 44,642 (305)
The relationship of cellular immunity to prognosis in acute leukemia [PDF]
, 1977 Forty-five patients with acute leukemia were compared on cellular immunity measures versus prognosis. The patients were treated according a multicombination therapy protocol. The purified protein derivative (PPD) test and dinitrochlorobenzene (DNCB) test
Chen, Pomin +6 more
core +1 more source
Frontiers in HematologyBackgroundDisease-specific factors associated with decreased quality of life (QoL) in patients with leukemia have not been studied in a large-scale, global, observational study.MethodsThis cross-sectional study used the validated Hematological Malignancy
Sam Salek +12 more
doaj +1 more source
The feasibility of PETHEMA ALL-96 regimen on treatment of patients with acute lymphoid leukemia
Journal of Research in Medical Sciences, 2023 Background: Asparaginase-based treatment regimen for acute lymphocytic leukemia (ALL) is considered as feasible, but there is still a lack of data. In this study, considering the results of other regimen that were not optimum in previous studies.
Farzaneh Ashrafi +3 more
doaj +1 more source
MedicinaBackground and Objectives: Leukemia, characterized by abnormal leukocyte production, exhibits clonal origin from somatic mutations. Globally, it ranked 15th in cancer incidence in 2020, with higher prevalence in developing countries.
Pablo Romero-Morelos +3 more
doaj +1 more source
Rare Coexistence of Acute Monoblastic Leukemia with Chronic Lymphocytic Leukemia
Case Reports in Hematology, 2018 Acute monoblastic leukemia (AMoL) is a rare hematopoietic neoplasm, and simultaneous occurrence of acute monoblastic leukemia with chronic lymphocytic leukemia is very rare and only a few cases have been reported in the literature.
Vikrant Singh Bhar +5 more
doaj +1 more source
Polytechnic Journal, 2021 The current study was revealed the seroprevalence of Toxoplasma gondii immunoglobulin (Ig)G and IgM among different types of leukemia (Acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin lymphoma [HL], multiple myeloma [MM], non-HL [NHL], and ...
Hemdad H. Mawlood
doaj +1 more source
Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia [PDF]
, 2013 Key Points First report demonstrating in vivo elimination of multiple LIC populations from childhood ALL cases using animal models. In vivo models of leukemia are essential for drug evaluation studies.
Blair, Allison +3 more
core +1 more source
Stage IV Small Lymphocytic Lymphoma Presenting with Unilateral Vision Loss
Case Reports in Oncological Medicine, 2020 Small lymphocytic lymphoma (SLL) is a manifestation of chronic lymphocytic leukemia (CLL) in which malignant B-cell lymphocytes accumulate in the lymph nodes or bone marrow. In this report, we describe the medical course of a patient diagnosed with stage
Christopher Le +4 more
doaj +1 more source
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML
Nature Communications, 2018 Histone demethylase JMJD3 is known to be oncogenic in preleukemic states and T-cell acute lymphocytic leukemia. Here, the authors show that in some acute myeloid leukemia subsets, JMJD3 can actually act as a potential oncorepressor via mediation of C ...
Shan-He Yu +8 more
doaj +1 more source
Einstein (São Paulo)Objective To analyze and compare the health-related quality of life of adult survivors of acute lymphocytic leukemia and Wilms’ tumor amongst themselves and in relation to healthy participants.
Clélia Marta Casellato de Souza +4 more
doaj +1 more source